[¹¹¹In]In-DTPA-mogamulizumab SPECT for imaging patient-derived adult T-cell leukemia/lymphoma cells in vivo.

Sho Koyasu

Presentation information

[WFNMB]Poster

The13th Congress of the World Federation of Nuclear Medicine and Biology(WFNMB2022) » [WFNMB]Poster Program

Nuclear Medicine Innovation2

Diagnosis

Sun. Sep 11, 2022 8:00 AM - 8:00 PM Web distribution only (配信のみ)

[WP-29-5] [¹¹¹In]In-DTPA-mogamulizumab SPECT for imaging patient-derived adult T-cell leukemia/lymphoma cells in vivo.

Sho Koyasu¹、Yoichi Shimizu¹、Takuya Shimizu²、Hiroki Tanaka¹、Takero Shindo²、Seiji Okada³、Akifumi Takaori²、Yuji Nakamoto¹ (1.Department of Radiology, Kyoto University Hospital、2.Department of Hematology, Kyoto University Hospital、3.Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University)

Abstract password authentication.The password is described on page 8 of the "WFNMB2022 Program"

Presentation information

Nuclear Medicine Innovation2

Diagnosis

[WP-29-5] [¹¹¹In]In-DTPA-mogamulizumab SPECT for imaging patient-derived adult T-cell leukemia/lymphoma cells in vivo.

Password